English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    M. М. Gunas, G. S. Moskovko, O. H. Ishchuk, I. V. Oleksiienko, V. I. Kyrychenko, I. V. Gunas

    FEATURES OF SOMATOTYPE COMPONENTS AND INDICATORS OF COMPONENT COMPOSITION OF BODY WEIGHT IN UKRAINIAN MEN AND WOMEN WITH MULTIPLE SCLEROSIS


    About the author: M. М. Gunas, G. S. Moskovko, O. H. Ishchuk, I. V. Oleksiienko, V. I. Kyrychenko, I. V. Gunas
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation In Ukrainian young men and women with multiple sclerosis, compared with practically healthy men and women, numerous significant or trends in the differences in the components of the Heath-Carter somatotype (mainly in women) and indicators of the component composition of body mass were established. Most of the differences in the components of the Heath-Carter somatotype and indicators of the component composition of body mass between patients with multiple sclerosis with mild, moderate and moderately severe disorders were established in men. Pronounced manifestations of sexual dimorphism were established only for most indicators of the component composition of body mass (except for fat) between men with multiple sclerosis (larger values in the general groups and in the groups of patients with mild and moderately severe disorders) and women.
    Tags nervous diseases,multiple sclerosis,somatotype,component composition of body mass,practically healthy and sick men and women
    Bibliography
    • Graf J, Akmatov MK, Meuth SG, Tremlett H, Holstiege J. Updated Multiple Sclerosis Incidence, 2015-2022. JAMA neurology. 2024 Oct 1;81(10):1100-2. doi: 10.1001/jamaneurol.2024.2876.
    • Harroud A, Manousaki D, Butler-Laporte G, Mitchell RE, Davey Smith G, Richards JB, et al. The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis. Multiple Sclerosis Journal. 2021 Nov;27(13):1994-2000. doi: 10.1177/1352458521995484.
    • Hawkes CH, Giovannoni G, Lechner-Scott J, Levy M. Is the incidence of multiple sclerosis really increasing?. Multiple sclerosis and related disorders. 2020 Oct 1;45. doi: 10.1016/j.msard.2020.102527.
    • Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nature Reviews Neurology. 2021 Nov;17(11):676-88. doi: 10.1038/s41582-021-00556-y.
    • Lane J, Ng HS, Poyser C, Lucas RM, Tremlett H. Multiple sclerosis incidence: A systematic review of change over time by geographical region. Multiple sclerosis and related disorders. 2022 Jul 1;63:103932. doi: 10.1016/j.msard.2022.103932.
    • López FG, García-Merino A, Alcalde-Cabero E, de Pedro-Cuesta J. Incidence and prevalence of multiple sclerosis in Spain: a systematic review. Neurología (English Edition). 2024 Oct 1;39(8):639-50. doi: 10.1016/j.nrleng.2022.02.004.
    • Lutfullin I, Eveslage M, Bittner S, Antony G, Flaskamp M, Luessi F, et al. Association of obesity with disease outcome in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 2023 Jan 1;94(1):57-61. doi: 10.1136/jnnp-2022-329685.
    • Marrodan M, Farez MF, Balbuena Aguirre ME, Correale J. Obesity and the risk of Multiple Sclerosis. The role of Leptin. Annals of Clinical and Translational Neurology. 2021 Feb;8(2):406-24. doi: 10.1002/acn3.51291.
    • Palavra F, Almeida L, Ambrósio AF, Reis F. Obesity and brain inflammation: a focus on multiple sclerosis. Obesity reviews. 2016 Mar;17(3):211-24. doi: 10.1111/obr.12363.
    • Pinhas‐Hamiel O, Livne M, Harari G, Achiron A. Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability. European journal of neurology. 2015 Sep;22(9):1275-9. doi:  10.1111/ene.12738.
    • Schreiner TG, Genes TM. Obesity and multiple sclerosis–A multifaceted association. Journal of Clinical Medicine. 2021 Jun 18;10(12):2689. doi: 10.3390/jcm10122689.
    • Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology. 2018;17(2):162-73. doi: 10.1016/S1474-4422(17)30470-2.
    • Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. The Lancet. 2018 Apr 21;391(10130):1622-36. doi: 10.1016/S0140-6736(18)30481-1.
    • Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, et al. Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Multiple Sclerosis Journal. 2015 Apr;21(4):388-95. doi: 10.1177/1352458514546785.
    Publication of the article «World of Medicine and Biology» №3(93), 2025 year, 057-062 pages, index UDK 616.832:572.087
    DOI 10.26724/2079-8334-2025-3-93-57-62